OOOzgur Akin Oto

Ozgur Akin Oto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ozgur Akin Oto has a total of 205 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinicopathologic features and outcomes of patients with DNAJB9-positive fibrillary glomerulonephritis

    by Ozge Hurdogan, Safak Mirioglu, Egemen Cebeci, Ahmet Burak Dirim, Sidar Bagbudar, Cagla Safak Karaoglan, Ayse Serra Artan, Ozgur Akin Oto, Isin Kilicaslan, Savas Ozturk, et al.

    Background: Fibrillary glomerulonephritis (FGN) is a very rare glomerular disease characterized by non-branching fibril deposition and DNAJB9 positivity. We aimed to analyze our cohort to better elucidate clinicopathologic features and outcomes of patients with FGN. Methods: Adult patients diagnosed with FGN between 2007 and 2025 and showing DNAJB9 positivity were included. Primary composite outcome was defined as doubling of serum creatinine from baseline, undergoing dialysis or transplantation, development of stage 5 chronic kidney disease or death. Results: Fifty native kidney biopsies of 44 patients were examined; 17 belonged to males (34%). Most common patterns of injury were mesangial (24, 48%) and membranoproliferative (16, 32%). Mean fibril diameter was 13.7 ± 2.5 nm. Eight biopsies (16%) showed atypical variants such as congophilia, light-chain restriction on frozen immunoflorescence and immunoglobulin G (IgG) negativity. Out of 44 patients, 25 (56.8%) had adequate follow-up data; the mean age was 48.4 ± 12.7 years. Over a median of 27 (7.5–89.5) months, 13 patients (52%) reached primary composite outcome, 10 (40%) underwent kidney replacement therapies and 3 (12%) died. Multivariate logistic regression models showed hemoglobin predicted the primary outcome whereas histopathological features or immunosuppressive use did not. Baseline serum C3 was associated with primary outcome (area under the curve 0.759, 0.525–0.916) with 134 mg/dL as cut-off value. The kidney survival rate was 30.8% in patients with serum C3 ≤134 mg/dL and 87.5% in serum C3 >134 mg/dL. However, multivariate regression models failed to show a clear association between serum C3 levels and primary outcome. Conclusions: Atypical histopathological features are not uncommon in FGN, complicating the differential diagnosis. Prognosis is still quite dismal despite immunosuppressive use. Lower baseline hemoglobin might indicate poorer outcomes.

  • Open Access

    Management of Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease

    by İsMail Koçyiğit, Emre Aydın, Özgür Akın Oto, Kadir Gökhan Atılgan, Etlik City Hospital Divison Of Nephrology, Tevfik Ecder

    Community health services,primary care,public health

  • Open Access

    F18-FDG PET/CT Findings in Kidney Graft Intolerance Syndrome

    by Yağmur Tahıllıoğlu, Rabia Hacer Hocaoğlu, Ayşe Serra Artan, Ahmet Burak Dirim, Duygu Has Şimşek, Özgür Oto Akın, Halil Yazıcı, Savaş Öztürk, Aydın Türkmen

    Cite this article as: Tahıllıoğlu Y, Hocaoğlu RH, Artan AS, et al. F18-FDG PET/CT findings in kidney graft intolerance syndrome. Turk J Nephrol. 2025;34(4):316-317.

  • Open Access

    Prognostic factors for long-term outcomes of unilateral atrophic kidneys in adult patients: a single-center retrospective cohort study

    by Zülal İsTemi̇hAn, Ahmet Burak Di̇rİm, Ali̇ Riza Uçar, Ceren Bağriaçik, Gamze Kemeç, Şafak Mi̇rİoĞlu, Seda Şafak, Vafa Suleymanova, Özgür Akin Oto, Ayşe Serra Artan, et al.

    Background/aim: Unilateral atrophic kidney (UAK) could be related to many etiologies that can cause chronic kidney disease in adults. There is limited data on the long-term outcome of adults with UAK in the literature. Materials and methods: This study included 199 adult patients with UAK. The etiology, baseline clinical/laboratory, and radiological findings were evaluated. Composite primary outcomes (CPO) (chronic kidney disease stage 5 or doubling of serum creatinine) and secondary outcomes (new-onset proteinuria (>0.5 g/day or g/g) or >50% increase in proteinuria level according to baseline, mortality, and nephrectomy requirement during follow-up) were evaluated in 166 patients with at least 3 months of follow-up. Results: Of 199 patients, 57.3% were female. The mean age at presentation was 44.4 years. Right and left kidney atrophy rates were 51.8% and 48.2%, respectively. Among the known etiologies, the most common was chronic pyelonephritis (17.1%, n = 34). Of 166 patients, 19 had a CPO. Patients with CPO had higher rates of hypertension (p = 0.033), proteinuria (p < 0.001), and renal artery stenosis. Baseline systolic blood pressure (p = 0.004) and serum creatinine (p < 0.001) were higher, and baseline eGFR (p < 0.001) and serum albumin (p = 0.001) were lower in these patients than in patients without CPO. Multivariate logistic regression analysis showed that baseline creatinine (p < 0.001), serum albumin (p = 0.034), and renal artery stenosis (p = 0.015) were independent risk factors for CPO. Conclusion: Higher baseline serum creatinine and lower serum albumin levels were associated with poor renal prognosis in adult patients with UAK. Also, UAK due to renal artery stenosis might be associated with worse outcomes than UAK related to other etiologies.

  • Open Access

    C-terminal TREX1 c.914A>G variant in a patient with IgA nephropathy and thrombotic microangiopathy: expanding the clinical and genetic spectrum of IgA nephropathy with microangiopathic lesions

    by Ahmet Burak Dirim, Elif Yilmaz Gulec, Ozge Hurdogan, Yasemin Ozluk, Safak Mirioglu, Ayse Serra Artan, Ozgur Akin Oto, Halil Yazici

  • Open Access

    Prediction of Recurrence and Graft Outcomes in Kidney Transplant Recipients with IgA Nephropathy: Role of Genetic and Oxidative Stress Markers

    by Ahmet Burak Dirim, Safak Mirioglu, Ozgur Akin Oto, Ayse Serra Artan, Yasemin Ozluk, Ozge Hurdogan, Sebahat Usta Akgul, Sonay Temurhan, Cigdem Kekik Cinar, Fatma Savran Oguz, et al.

    Background: IgA nephropathy (IgAN) recurrence a"er kidney transplantation (KTx) could cause allogra" loss. New bio markers are needed to assess the risk of IgAN recurrence and allogra" dysfunction following KTx. Methods: Thirty-seven KTx recipients who underwent KTx between 2002-2011 with biopsy-confirmed pre-transplant IgAN were evaluated in this retrospective study. Demographics, pathological and clinical/laboratory findings, and biomarkers, including levels of advanced oxidative protein products (AOPP) and galactose-deficient IgA1 and 4 tag single-nucleotide variants (tSNVs) associated with IgAN, were recorded. The primary outcome was IgAN recurrence. Biopsy-proven allogra" rejection (BPAR) and death-censored gra" failure (DCGF) were secondary outcomes. Results: 72.9% of patients were male. The mean age of KTx recipients was 37.4 ± 9.9 years. 45.9% of them experienced a recurrence of IgAN, during a median of 125 months of follow-up. There were more male donors in the recurrent IgAN group (P = .022). The median levels of UPCR were higher (P = .002) and estimated glomerular filtration rate (eGFR) were lower (P = .007) at the time of sampling in the recurrent group. Donor sex (male) (P = .018, HR: 3.853, 95% CI: 1.256-11.826) and eGFR at sampling (P = .039, HR: 0.967, 95% CI: 0.937-0.998) were predictors of IgAN recurrence in Cox regression analysis. Advanced oxidative protein products (median 78.4 vs 67.35 (#mol/L)) and Gd-IgA1 (median 5390.3 vs 4732.5 ng/#L) levels were insignificantly elevated in the patients with IgAN recurrence. Statistical di$erences were not present in terms of sec ondary outcomes between the patients with and without IgAN recurrence. Single-nucleotide variants were not statistically associated with the recurrence of IgAN. Conclusions: Prospective biomarker/genetic marker studies, including large patient cohorts, are required to evaluate the risk of IgAN recurrence and allogra" function a"er KTx. Cite this article as: Dirim AB, Mirioglu S, Oto OA, et!al. Prediction of recurrence and gra" outcomes in kidney transplant recipients with IgA nephropathy: role of genetic and oxidative stress markers. Turk J Nephrol. 2025;34(2):124-133.

  • Side Effects of Immunosuppressive Treatments in Primary Glomerulonephritis

    by Tuba Yuce Inel, Halil Yazıcı, Özgür Akın Oto, Erol Demir, Fsdime Sevgi Saçlı, Ali Rıza Uçar, Ahmet Burak Dirim, Savaş Öztürk, Aydın Türkmen

    Background: It is imperative to closely monitor patients for adverse effects of immunosuppressive (IS) agents, widely used in treating glomerulonephritis (GN). Our study aimed to investigate the occurrence of any drug-related adverse events in patients with primary GN, explicitly focusing on IS. Methods: The present study analyzed 162 adult GN patients treated with IS drugs. The study scrutinized the demographic and clinical profiles of the patients, laboratory findings, and any side effects associated with IS drugs. We further investigated the patients for frequency and nature of infections, musculoskeletal and gastrointestinal symptoms, thromboembolism, new-onset diabetes, avascular necrosis, neuropsychiatric side effects, and premalignant conditions. Results: The study comprised a diverse group of patients with a male majority of 51.9% and a mean age of 37.2±12.9 years. The patients were under clinical observation for an average of 69.6±40.1 months, and during the treatment, 71% experienced at least one adverse effect. After evaluating the data, we did not find a significant correlation between the GN type and the presence of side effects. Research demonstrates that patients receiving corticosteroids (CS) exhibit a higher incidence of myopathy than those receiving other IS therapies (p=0.001). Hypoalbuminemia (OR: 2.05; 95% CI: 1.82–2.28; p =0.001) and steroid treatment (OR: 1.04; 95% CI: 1.01–1.06; p = 0.009) are significantly associated with increased risk of adverse outcomes. Conclusion: In cases of GN, it is not unusual for patients to encounter adversities associated with IS treatment, primarily when there is a comorbidity of hypoalbuminemia and CS exposure. The probability of these side effects occurring may increase under such circumstances. Main Points: • Patients diagnosed with GN should undergo meticulous monitoring to detect any potential adverse effects that may arise from the administration of IS agents • The probability of experiencing side effects is higher when hypoalbuminemia and CS exposure are present. • The present study suggests no discernible correlation between the type of GN and side effects.

  • Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey

    by Ilyas Ozturk, Ozkan Gungor, Savas Ozturk, Refik Olmaz, Ayse Jini Gunes Keskin, Ismail Kocyigit, Murat Hayri Sipahioglu, Fatih Dede, Sena Ulu, Kenan Turgutalp, et al.

    Background Each year, millions face natural disasters, encountering mass fatalities and severe medical issues such as crush injuries and crush syndrome. Crush syndrome, marked by acute kidney injury (AKI) and hyperkalemia, correlates with mortality. This study focuses on presenting epidemiological data on kidney disease resulting from the February 6, 2023 earthquakes centered in Kahramanmaras. Methods This retrospective analysis included patients diagnosed with crush syndrome after the 2023 Kahramanmaras earthquakes, treated in regional hospitals or referred elsewhere in Turkey. Patient data were documented using the web-based system developed by the Turkish Nephrology Association Renal Disaster Working Group. Results Of the 1024 analyzed patients from 46 centers, 515 (50.3%) were women. The mean age was 41 ± 16 years, with a median duration of 12 h under rubble, and the median presentation time to the first health facility was 4 h after extrication from the rubble. Upon admission, 79.8% received intravenous fluid therapy, all potassium-free. Initial serum creatinine, K+, and creatinine kinase levels averaged 2.59 ± 2 mg/dl, 5.1 ± 1 mmol/L 38,305 ± 54,303 U/L, respectively. Intensive care unit (ICU) admissions were 53.6%, with mean hospital and ICU stays of 20 and 11 days, respectively. Compartment syndrome occurred in 40.8% of patients, with 75.8% undergoing fasciotomy. Acute kidney injury developed in 67.9% of patients, with 70.3% undergoing hemodialysis, totaling 3016 sessions on 488 patients. The overall in-hospital mortality rate was 9.8%. Conclusion Earthquakes have a significant impact on kidney health. Although our study indicates some progress compared to previous earthquake responses, there remains a crucial need for drills emphasizing post-earthquake initial response, fluid-electrolyte balance management, and emergency dialysis protocols. Graphical abstract


  • Open Access

    Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use

    by Safak Mirioglu, Rabia Hacer Hocaoglu, Arzu Velioglu, Yasemin Ozluk, Ahmet Burak Dirim, Aysegul Oruc, Ozgur Akin Oto, Halil Yazici, Yasar Caliskan


  • Open Access

    LIM Zinc Finger Domain Containing 1 Risk Genotype of Recipient Is Associated with Renal Tubular Inflammation in Kidney Transplantation

    by Yasar Caliskan, Yasemin Ozluk, Kento Kurashima, Safak Mirioglu, Ahmet Burak Dirim, Ozge Hurdogan, Ozgur Akin Oto, Marzena Syn, Mustafa Nazzal, Ajay Jain, et al.

    Background: Homozygosity for LIMS1 rs893403-GG genotype is linked to an increased risk of allograft rejection after kidney transplantation. Ischemia-reperfusion of the kidney allograft leads to long term infiltration of activated and effector-memory T lymphocytes and resulting in rejection and long-term fibrosis. However, the genotype, LIMS1 expression under ischemic conditions and the long-term histopathological relationships remain ill-defined. Methods: We examined the impact of the recipient’s LIMS1-rs893403 genotype with transplant kidney histopathology. The association of the LIMS1-rs893403 genotype and LIMS1 and GCC2 mRNA expression in ischemic donor kidneys were also examined. Recipients who underwent transplant kidney biopsy were genotyped for the LIMS1-rs893403 variant and associated deletion. Histopathological findings were compared between recipients with LIMS1 risk and non-risk genotypes. Real-time PCR and immunofluorescence staining for LIMS1 and GCC2 expression were performed in non-utilized donor kidneys. Results: Demographic, clinical, and treatment characteristics and the histopathological diagnosis were similar between recipients with rs893403 GG and AA/AG genotype. The Banff tubulitis score was higher in GG recipients (n = 24) compared to AA/AG (n = 86) recipients (1.42 ± 0.65 vs. 1.12 ± 0.66, p = 0.03). Ischemic kidneys with GG showed higher LIMS1 and GCC2 mRNA expression than kidneys with AG. Kidneys with rs893403-GG had higher tubular LIMS1 and GCC2 immunohistochemical staining compared to kidneys with rs893403-AG. Conclusions: Our data supports the role of the LIMS1 locus in kidney transplant rejection, particularly in lymphocyte infiltration into the internal aspect of the tubular basement membranes. Increased LIMS1 and GCC2 expression in ischemic donor kidneys with the GG genotype require further studies.